Tart Cherry
Tart Cherry is a pharmaceutical drug with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms
Tart Cherries - The Influence on Acute Adaptation
Recovery With Tart Cherry Supplementation Following a Marathon.
Plasma-Induced Changes in the Metabolome Following Polyphenol Consumption
Comparison of Acute Tart Cherry Supplement Formulation and Dose on Inflammation and Oxidative Capacity
Clinical Trials (7)
Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms
Tart Cherries - The Influence on Acute Adaptation
Recovery With Tart Cherry Supplementation Following a Marathon.
Plasma-Induced Changes in the Metabolome Following Polyphenol Consumption
Comparison of Acute Tart Cherry Supplement Formulation and Dose on Inflammation and Oxidative Capacity
Polyphenol Rich Supplementation on Markers of Recovery From Intense Resistance Exercise
Tart Cherry, Metabolic Syndrome, and Cardiovascular Risk
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7